These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6728887)

  • 1. Factorial design of experiment for stability studies in the development of a tablet formulation.
    El-Banna HM; Ismail AA; Gadalla MA
    Pharmazie; 1984 Mar; 39(3):163-5. PubMed ID: 6728887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The construction and uses of factorial designs in the preparation of solid dosage forms.
    El-Banna HM; Boraie N; El-Shibini HA
    Pharmazie; 1981 Dec; 36(12):819-23. PubMed ID: 7330083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization study on the formulation of roxithromycin dispersible tablet using experimental design.
    Weon KY; Lee KT; Seo SH
    Arch Pharm Res; 2000 Oct; 23(5):507-12. PubMed ID: 11059832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naproxen-Eudragit microspheres: screening of process and formulation variables for the preparation of extended release tablets.
    Zaghloul AA; Faltinek J; Vaithiyalingam SR; Reddy IK; Khan MA
    Pharmazie; 2001 Apr; 56(4):321-4. PubMed ID: 11338673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a rapidly dispersing tablet of a poorly wettable compound: formulation DOE and mechanistic study of effect of formulation excipients on wetting of celecoxib.
    He X; Barone MR; Marsac PJ; Sperry DC
    Int J Pharm; 2008 Apr; 353(1-2):176-86. PubMed ID: 18207339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EFFECT OF FORMULATION AND PROCESS VARIABLES ON THE RELEASE, MECHANICAL AND MUCOADHESIVE PROPERTIES OF IBUPROFEN TABLET FORMULATIONS.
    Adetunji OA; Odeniyi MA; Itiola OA
    Acta Pol Pharm; 2015; 72(2):357-65. PubMed ID: 26642687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of disintegration-promoting agent, lubricants and moisture treatment on optimized fast disintegrating tablets.
    Late SG; Yu YY; Banga AK
    Int J Pharm; 2009 Jan; 365(1-2):4-11. PubMed ID: 18778759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of amlodipine besylate and atenolol in multi-component tablets of mono-layer and bi-layer types.
    Aryal S; Skalko-Basnet N
    Acta Pharm; 2008 Sep; 58(3):299-308. PubMed ID: 19103566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent trends in stabilising peptides and proteins in pharmaceutical formulation - considerations in the choice of excipients.
    Jorgensen L; Hostrup S; Moeller EH; Grohganz H
    Expert Opin Drug Deliv; 2009 Nov; 6(11):1219-30. PubMed ID: 19678792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stabilization of the maleate salt of a basic drug by adjustment of microenvironmental pH in solid dosage form.
    Zannou EA; Ji Q; Joshi YM; Serajuddin AT
    Int J Pharm; 2007 Jun; 337(1-2):210-8. PubMed ID: 17296277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The construction and uses of factorial designs in the preparation of solid dosage forms. Part 3. Effect of temperature and time on the mechanical properties of sintered tablets.
    El-Banna HM; Boraie N; El-Shibini HA
    Pharmazie; 1981 Nov; 36(11):772-5. PubMed ID: 7323126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapidly absorbed orodispersible tablet containing molecularly dispersed felodipine for management of hypertensive crisis: development, optimization and in vitro/in vivo studies.
    Basalious EB; El-Sebaie W; El-Gazayerly O
    Pharm Dev Technol; 2013; 18(2):407-16. PubMed ID: 22339303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generalized regression neural networks in prediction of drug stability.
    Ibrić S; Jovanović M; Djurić Z; Parojcić J; Solomun L; Lucić B
    J Pharm Pharmacol; 2007 May; 59(5):745-50. PubMed ID: 17524242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compression behavior of formulations from Phyllanthus niruri spray dried extract.
    De Souza TP; Gómez-Amoza JL; Martínez-Pacheco R; Petrovick PR
    Pharmazie; 2006 Mar; 61(3):213-7. PubMed ID: 16599262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statistical method for evaluation of dissolution stability in the formulation development of solid dosage forms: tablets of amonafide.
    Gil-Alegre ME; Bernabeu JA; Camacho MA; Torres-Suarez AI
    Pharmazie; 2004 Jul; 59(7):541-7. PubMed ID: 15296092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of bilayer floating tablet containing metoprolol tartrate as a model drug for gastric retention.
    Narendra C; Srinath MS; Babu G
    AAPS PharmSciTech; 2006 Apr; 7(2):E34. PubMed ID: 16796352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the physical properties of tablets and tablet excipients. V. Film coating for protection of a light-sensitive tablet-formulation.
    Nyqvist H; Nicklasson M; Lundgren P
    Acta Pharm Suec; 1982; 19(3):223-8. PubMed ID: 7113729
    [No Abstract]   [Full Text] [Related]  

  • 18. [Shelf-life estimation of pharmaceutical products by matrixing].
    Yoshioka S; Aso Y; Kojima S
    Eisei Shikenjo Hokoku; 1996; (114):143-4. PubMed ID: 9037887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of excipients and technological process on cholecalciferol stability and its liberation from tablets.
    Sawicka J
    Pharmazie; 1991 Jul; 46(7):519-21. PubMed ID: 1664519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of pH-independent release of nicardipine hydrochloride extended-release matrix tablets using response surface methodology.
    Huang YB; Tsai YH; Lee SH; Chang JS; Wu PC
    Int J Pharm; 2005 Jan; 289(1-2):87-95. PubMed ID: 15652202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.